The homogeneous yellow solution was transferred to Teflon-lined stainless-steel autoclave and heated at 200C for nearly 8 hours, and cooled to room temperature. the saline and Fe3O4@SiO2. The decrease of tumor signal by A-MFS was much more significant than that by saline and Fe3O4@SiO2(P<0.05). The results exhibited the high stability and nontoxicity of A-MFS, which effectively targeted pancreatic malignancy in vitro and in vivo. A-MFS is a encouraging agent for diagnosis of pancreatic malignancy. Keywords:nanoprobe, mesothelin, Fe3O4@SiO2, pancreatic malignancy, targeted imaging == Introduction == Pancreatic malignancy is one of the most highly malignant tumors with comparable rates of incidence and mortality. Research advances over the past few decades failed to improve the survival rate. The overall 5-year survival rate still remains <5% since most patients newly diagnosed with pancreatic malignancy have already advanced in the disease and are not amenable to surgical therapy.14Early and definitive diagnosis and prompt therapy significantly improve the prognosis and increase survival rates.5Molecular imaging is a potential way to improve early diagnosis. Molecular imaging of biological processes in vivo enables the detection of molecular and cellular mutations and the pathological changes at an early stage of the disease and promotes early diagnosis and treatment.68CA19-9 is a clinical biomarker widely DPM-1001 used, but lacks specificity and sensitivity for early diagnosis of pancreatic malignancy.9,10Therefore, discovery of highly-specific tumor biomarkers is imperative. Nanomedicine entails application of nanoscience and technology to medicine. Targeted labeling entails combining nanosized materials with biomarkers to synthesize multifunctional complexes and target functional biomarkers to specific cells or tissues in vitro and in vivo. In recent decades, several serum and tissue biomarkers in pancreatic malignancy have exhibited the benefit of early diagnosis. The high-molecular excess weight mucins are a family of extracellular proteins that are greatly glycosylated with complex oligosaccharides and play an important role in tumor formation and progression.11Mucins 1 DPM-1001 and 4 are associated with pancreatic malignancy.12,13A study14suggest that BxPC-3 and Panc-1 cell lines of pancreatic cancer express mucin 1. They also exhibited that subcutaneous and orthotopic tumor transplantation emits strong fluorescence signals after injection of fluorophore-conjugated anti-MUC1 antibodies via nude mice tail veins. Wu et al15prepared new multifunctional nanoparticles (MnMEIO-silane-NH2-[MUC4]-mPEG nanoparticles) made up of MUC4 antibodies as a new type of magnetic resonance imaging (MRI) and optical imaging contrast agent. The new type of contrast agent selectively and specifically targeted mucin-expressing tumor tissues in nude mice. Survivin gene, which is a member of the inhibitor of apoptosis family, is usually abundantly expressed DPM-1001 in the serum of most pancreatic malignancy patients.16,17Tong et al18synthesized a survivin gene-targeted magnetic iron oxide nanoparticle with high stability and without any toxicity. The magnetic molecular probe selectively targeted the pancreatic malignancy cells with survivin gene expression. Urokinase plasminogen activator receptor, a cellular receptor, is expressed in >86% of pancreatic malignancy tissues, but not in normal or chronic pancreatitis tissues. It also contributes to tumor progression.19,20Studies have shown that urokinase plasminogen activator receptor-targeted nanoparticles selectively accumulate in transplanted tumor lesions of human pancreatic malignancy in nude mice.21Despite advances involving new biomarkers for pancreatic cancer, none of them has been validated for routine DPM-1001 clinical use. Therefore, additional studies have been undertaken to develop or discover specific markers targeting pancreatic malignancy and generate novel nanoparticles for clinical use. Mesothelin (MSLN), which is overexpressed in several tumors, such as mesothelioma, ovarian malignancy, and pancreatic malignancy, is a 40 kDa cell surface glycoprotein. It is selectively expressed in malignant pancreatic malignancy tissue, but not in pancreatic benign tumors, acute or chronic pancreatitis, and normal pancreatic tissues.22,23MSLN plays an important role in the development of pancreatic malignancy in different ways. The overexpression of MSLN promotes the motility, increases the proliferation, and inhibits CTLA1 the apoptosis of pancreatic malignancy cells, and is associated with tumor invasion and migration. Strong expression of MSLN usually indicates poor prognosis. 2427It is considered as a potential and encouraging diagnostic, imaging, and therapeutic biomarker in pancreatic malignancy.28 Fe3O4nanoparticles are the most common superparamagnetic iron oxide components used as multifunctional nanoparticles. Their unique superparamagnetic properties, biocompatibility, and ease of preparation have wide biomedical applications.29,30Silica is.